Rankings
▼
Calendar
IMA Q4 2024 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$5M
Operating Income
-$13M
Net Income
-$9M
EPS (Diluted)
$-0.19
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$998,000
Balance Sheet
Total Assets
$142M
Total Liabilities
$16M
Stockholders' Equity
$126M
Cash & Equivalents
$39M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$659,000
-100.0%
Gross Profit
-$5M
$354,000
-1393.8%
Operating Income
-$13M
-$22M
+42.9%
Net Income
-$9M
-$19M
+53.2%
← FY 2024
All Quarters
Q1 2025 →